Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at Reducing Alcohol Consumption
Tampa, Fla. (PRWEB) August 12, 2021 -- Psilera Inc. (“Psilera”), a Florida-based biotechnology company specializing in the clinical development of
Source: prweb.com